AbstractWithin the complex pathological picture associated to diabetes, high glucose (HG) has “per se” effects on cells and tissues that involve epigenetic reprogramming of gene expression. In fetal tissues, epigenetic changes occur genome-wide and are believed to induce specific long term effects. Human umbilical vein endothelial cells (HUVEC) obtained at delivery from gestational diabetic women were used to study the transcriptomic effects of chronic hyperglycemia in fetal vascular cells using Affymetrix microarrays. In spite of the small number of samples analyzed (n=6), genes related to insulin sensing and extracellular matrix reorganization were found significantly affected by HG. Quantitative PCR analysis of gene promoters identified ...
NoGestational diabetes mellitus (GDM) is known to be associated with fetal endothelial dysfunction, ...
[[abstract]]Diabetes is a debilitating metabolic disorder resulting from hyperglycemia and glucose i...
The current goal of diabetes therapy is to reduce time-averaged mean levels of glycemia, measured as...
Within the complex pathological picture associated to diabetes, high glucose (HG) has ". per se" eff...
AbstractWithin the complex pathological picture associated to diabetes, high glucose (HG) has “per s...
DNA methylation, a critical epigenetic mechanism, plays an important role in governing gene expressi...
AIMS/HYPOTHESIS: An adverse intrauterine environment can result in permanent changes in the physiolo...
Background: Glycemic control is a strong predictor of long-term cardiovascular risk in patients with...
Background: Glycemic control is a strong predictor of long-term cardiovascular risk in patients with...
poster abstractGestational diabetes (GDM) complicates up to 10% of pregnancies. In addition to acute...
Background: Gestational diabetes mellitus (GDM) affects approximately 10% of pregnancies in the Unit...
Enhanced biosynthesis of several cytokines, such as, transforming growth factor-β1 (TGF-β1), is dete...
Background: Gestational diabetes mellitus (GDM) affects approximately 10% of pregnancies in the Unit...
Enhanced biosynthesis of several cytokines, such as, transforming growth factor-\u3b21 (TGF-\u3b21),...
Objective: Gestational diabetes mellitus (GDM) produces fetal hyperglycemia with increased lifelong ...
NoGestational diabetes mellitus (GDM) is known to be associated with fetal endothelial dysfunction, ...
[[abstract]]Diabetes is a debilitating metabolic disorder resulting from hyperglycemia and glucose i...
The current goal of diabetes therapy is to reduce time-averaged mean levels of glycemia, measured as...
Within the complex pathological picture associated to diabetes, high glucose (HG) has ". per se" eff...
AbstractWithin the complex pathological picture associated to diabetes, high glucose (HG) has “per s...
DNA methylation, a critical epigenetic mechanism, plays an important role in governing gene expressi...
AIMS/HYPOTHESIS: An adverse intrauterine environment can result in permanent changes in the physiolo...
Background: Glycemic control is a strong predictor of long-term cardiovascular risk in patients with...
Background: Glycemic control is a strong predictor of long-term cardiovascular risk in patients with...
poster abstractGestational diabetes (GDM) complicates up to 10% of pregnancies. In addition to acute...
Background: Gestational diabetes mellitus (GDM) affects approximately 10% of pregnancies in the Unit...
Enhanced biosynthesis of several cytokines, such as, transforming growth factor-β1 (TGF-β1), is dete...
Background: Gestational diabetes mellitus (GDM) affects approximately 10% of pregnancies in the Unit...
Enhanced biosynthesis of several cytokines, such as, transforming growth factor-\u3b21 (TGF-\u3b21),...
Objective: Gestational diabetes mellitus (GDM) produces fetal hyperglycemia with increased lifelong ...
NoGestational diabetes mellitus (GDM) is known to be associated with fetal endothelial dysfunction, ...
[[abstract]]Diabetes is a debilitating metabolic disorder resulting from hyperglycemia and glucose i...
The current goal of diabetes therapy is to reduce time-averaged mean levels of glycemia, measured as...